RBC Capital Markets recently released a research report downgrading Select Medical Holdings Corporation's stock rating from "Outperform" to "Sector Perform".

The institution has also significantly reduced its target share price from $19 per share to $16.5 per share, a decrease of 13.2%. This rating adjustment reflects analysts' cautious attitude toward the company's short-term performance outlook. Although Select Medical maintains a leading position as a specialized medical service provider in the fields of rehabilitation hospitals and specialty outpatient clinics, current operational cost pressures and changes in the policy environment within the healthcare industry may pose challenges to its profit growth. The downward adjustment of the target price indicates that analysts have reassessed the company's valuation level. The new target price of $16.5 still offers upside potential compared to the current share price, but it is noticeably closer to previous expectations, which may suggest that institutional investors hold a more conservative outlook on its future growth pace.